Tokyo, Japan

Wakao Sato


Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 78(Granted Patents)


Location History:

  • Chiba, JP (1993)
  • Tokyo, JP (1992 - 1995)

Company Filing History:


Years Active: 1992-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wakao Sato: Innovator in Anticancer Drug Potentiation

Introduction

Wakao Sato is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that enhance the efficacy of anticancer drugs. With a total of 4 patents to his name, Sato's work is pivotal in the ongoing fight against cancer.

Latest Patents

Sato's latest patents include innovative quinoline derivatives that serve as heterocyclic compounds. These compounds are useful as anticancer drug potentiaters, possessing a unique ability to enhance the incorporation of anticancer drugs into cancer cells. The synthesis of these compounds involves reacting an epoxy compound, derived from a heterocyclic compound and an epihalogenohydrin, with an amine derivative. This groundbreaking work has the potential to significantly improve cancer treatment outcomes.

Career Highlights

Wakao Sato is currently employed at Mitsui Toatsu Chemicals, Incorporated, where he continues to advance his research in medicinal chemistry. His expertise and innovative approach have positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Sato collaborates with esteemed colleagues such as Nobuyuki Fukazawa and Makoto Odate. Their combined efforts contribute to the advancement of research in the field of anticancer drug development.

Conclusion

Wakao Sato's contributions to the field of medicinal chemistry, particularly in the area of anticancer drug potentiation, highlight his role as an influential inventor. His innovative patents and collaborations are paving the way for more effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…